What this means
This is a trial that is still signing up people. It will compare two supplements with a fake capsule over 12 weeks. No results have been posted, so we cannot yet say whether either one helps.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50–75
- Where
- 1 site, including Florida
The science
- Registered title
- The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health
- Trial ID
- NCT07760506 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Healthy Aging, Inflammaging, Metabolic Health, Quercetin, Coenzyme Q10
- What is tested
- Quercetin (dietary supplement), Coenzyme Q10, Rice Flour
- Sponsor
- Applied Science & Performance Institute
- Ages
- 50 Years to 75 Years
- Dates
- First posted Aug 12, 2026 · updated Sep 17, 2026
Registry summary
The goal of this clinical trial is to learn if Quercefit® or Ubiqsome™ can improve markers of healthy aging, blood sugar control, and heart health in older adults. It will also learn about the safety of these supplements.
The main questions it aims to answer are:
- Do Quercefit® or Ubiqsome™ improve blood sugar, cholesterol, and markers of aging compared to a placebo?
- What side effects, if any, do participants have while taking these supplements?
Researchers will compare Quercefit® (500 mg/day), Ubiqsome™ (300 mg/day), and a placebo (a look-alike capsule with no active ingredient).
Participants will:
- Take their assigned capsules (Quercefit®, Ubiqsome™, or placebo) twice daily for 12 weeks
- Go to a preferred clinic at the start and end of the study for a fasting blood draw
Complete at-home tests:
- Grip strength testing (using a device mailed to them)
- Online surveys about fatigue and quality of life
- Report any side effects and keep track of supplement use
Sites (1)
- The Applied Science and Performance Institute, Tampa, Florida, United States